arrow
R

Rachel Howells

chemistry, oncology r&d, astrazeneca, cambridge cb2 0aa, u.k.
H指数:14
被引数:913

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthetic chemistry enabling the discovery and development of a series of pyrazoles as HPK1 inhibitors

合成化学使一系列作为HPK1抑制剂的吡唑的发现和开发成为可能

2025-08-140
PRE
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor

吡嗪羧酰胺AZ3246的发现与优化:一种选择性HPK1抑制剂

2025-02-102
PRE
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRASG12C with Demonstrable CNS Penetration

AZD4747的发现,这是一种有效且选择性的突变体GTPase KRASG12C抑制剂,具有明显的中枢神经系统穿透性

2023-07-0311
PRE
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the MutantGTPase KRASG12C

突变gtpase KRASG12C的共价变构抑制剂AZD4625的发现

2022-04-2637
PRE
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
2020-02-0560
PREAI
Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)
2019-11-1150
PREAI
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome

AZD8421的发现:一种对其他CDK家族成员及人激酶组具有选择性的强效CDK2抑制剂

0
PRE